Auscann Group Holdings Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Auscann Group Holdings Ltd with three other
pharmaceutical manufacturers in Australasia:
Incannex Healthcare Ltd
(2019
sales of 1.18 million Australian Dollars [US$821,803.27 ]
),
ECS Botanics Holdings Ltd
(1,384.00 Australian Dollars [US$965.13 ]
), and
Orthocell Ltd
(956,472.00 Australian Dollars [US$666,995.75 ]
).
Sales Analysis.
Sales increased substantially in 2019:
Auscann Group Holdings Ltd reported sales of A$861,770.00 (US$600.96 thousand)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 266.6%
versus 2018, when the company's sales were A$235,064.00 .
This was the third consecutive year of growth at Auscann Group Holdings Ltd.